Dr. Feng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The Oregon Clinic ENT West
9155 SW Barnes Rd Suite 536
Portland, OR 97225Phone+1 503-935-8100Fax+1 503-935-8110
Summary
- Dr. Zipei Feng is an otolaryngologist in Portland, OR and is affiliated with The Oregon Clinic. He received his medical degree from Oregon Health and Science University School of Medicine. He completed his residency in Otolaryngology Head Neck Surgery at Baylor College of Medicine, and subsequently fellowship in Head Neck Surgery and Microvascular Reconstruction at Stanford University Medical Center. He specializes in head neck microvascular surgery and head neck oncologic surgery. He has more than 25 publications and over 1000 citings.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2023 - 2024
- Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2018 - 2023
- Oregon Health and Science University School of MedicineClass of 2015
Certifications & Licensure
- CA State Medical License 2023 - 2025
- OR State Medical License 2024 - 2025
Publications & Presentations
PubMed
- 12 citationsSTING expression and response to treatment with STING ligands in premalignant and malignant disease.Jason R Baird, Zipei Feng, Hong D Xiao, David Friedman, Ben Cottam
Plos One. 2017-01-01 - 1330 citationsInternational validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyFranck Pagès, Bernhard Mlecnik, Florence Marliot, Gabriela Bindea, Fang Shu Ou
Lancet. 2018-05-26 - 49 citationsActivation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.Brittany L. Allen-Petersen, Tyler Risom, Zipei Feng, Zhiping Wang, Zina P. Jenny
Cancer Research. 2019-01-01
Journal Articles
- Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrett Sheppard, Charles D Lopez, Zipei Feng, Clinical Cancer Research
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: